PRESS RELEASE
14 March 2025

Lowenstein Represents PerkinElmer In Acquisition Of Project Farma, Expanding OneSource Professional Services Offering For The Life Sciences Industry

LS
Lowenstein Sandler

Contributor

Lowenstein Sandler is a national law firm with over 350 lawyers working from five offices in New York, Palo Alto, New Jersey, Utah, and Washington, D.C. We represent clients in virtually every sector of the global economy, with particular strength in the areas of technology, life sciences, and investment funds.
Lowenstein Sandler represented PerkinElmer, a global leader in analytical solutions and specialized services for (bio)pharma...
United States

Lowenstein Sandler represented PerkinElmer, a global leader in analytical solutions and specialized services for (bio)pharma, applied and food markets, in the acquisition of Project Farma, a subsidiary of Precision for Medicine.

Project Farma is a leading life sciences consultancy focused on advancing technical operations from ideation through commercialization, offering project management, project controls, commissioning, qualification and validation, quality compliance and engineering consulting services.

The Lowenstein team included David L. Goret, Michael J. Reinhardt, Lauren E. Vanderdrift, Nicola E. Perzichilli, Bryan Sterba, Megan Monson, Sophia Mokotoff, Eric Jesse, Craig Dashiell, Nicholas G. Mehler, Amy C. Schwind, Mark S. Heinzelmann, James C. Shehan, Manali Joglekar, Jessica I. Kriegsfeld, Amani Taha, Chloe Rippe, and Hannah Pastore.

Contributor

Lowenstein Sandler is a national law firm with over 350 lawyers working from five offices in New York, Palo Alto, New Jersey, Utah, and Washington, D.C. We represent clients in virtually every sector of the global economy, with particular strength in the areas of technology, life sciences, and investment funds.

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More